Category icon
The Science of Ultrasound Renal Denervation

Philipp Lurz, Michael Joner, Felix Mahfoud et al

Category icon
The New Era in AF Screening at Home

Bernd Sanner, Keitaro Senoo, Faizel Osman

Category icon
Atrial Arrhythmias in Pulmonary Hypertension

Brett Wanamaker, Thomas Cascino, Vallerie V McLaughlin, et al

Category icon
The New Era in AF Screening at Home

Bernd Sanner, Keitaro Senoo, Faizel Osman

Category icon
Atrial Arrhythmias in Pulmonary Hypertension

Brett Wanamaker, Thomas Cascino, Vallerie V McLaughlin, et al

Category icon
The Science of Ultrasound Renal Denervation

Philipp Lurz, Michael Joner, Felix Mahfoud et al

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles

Articles

Article icon
Atrial Arrhythmias in Pulmonary Hypertension

Brett Wanamaker, Thomas Cascino, Vallerie V McLaughlin,

Citation: Arrhythmia & Electrophysiology Review 2018;7(1):43–8.